annual EBITDA:
$9.11B-$1.44B(-13.64%)Summary
- As of today (April 18, 2025), ABT annual EBITDA is $9.11 billion, with the most recent change of -$1.44 billion (-13.64%) on December 31, 2024.
- During the last 3 years, ABT annual EBITDA has fallen by -$3.18 billion (-25.86%).
- ABT annual EBITDA is now -25.86% below its all-time high of $12.28 billion, reached on December 31, 2021.
Performance
ABT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$2.54B-$343.00M(-11.90%)Summary
- As of today (April 18, 2025), ABT quarterly EBITDA is $2.54 billion, with the most recent change of -$343.00 million (-11.90%) on December 31, 2024.
- Over the past year, ABT quarterly EBITDA has dropped by -$227.00 million (-8.20%).
- ABT quarterly EBITDA is now -33.68% below its all-time high of $3.83 billion, reached on March 31, 2022.
Performance
ABT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$10.36B-$227.00M(-2.14%)Summary
- As of today (April 18, 2025), ABT TTM EBITDA is $10.36 billion, with the most recent change of -$227.00 million (-2.14%) on December 31, 2024.
- Over the past year, ABT TTM EBITDA has dropped by -$187.00 million (-1.77%).
- ABT TTM EBITDA is now -25.76% below its all-time high of $13.95 billion, reached on June 30, 2022.
Performance
ABT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ABT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.6% | -8.2% | -1.8% |
| 3 y3 years | -25.9% | -8.2% | -1.8% |
| 5 y5 years | +17.3% | -8.2% | -1.8% |
ABT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.9% | at low | -33.7% | +11.3% | -25.8% | +3.0% |
| 5 y | 5-year | -25.9% | +17.3% | -33.7% | +71.0% | -25.8% | +42.5% |
| alltime | all time | -25.9% | +1030.8% | -33.7% | +194.0% | -25.8% | +820.3% |
Abbott Laboratories EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $9.11B(-13.6%) | $2.54B(-11.9%) | $10.36B(-2.1%) |
| Sep 2024 | - | $2.88B(+13.0%) | $10.58B(+2.1%) |
| Jun 2024 | - | $2.55B(+7.1%) | $10.36B(-0.4%) |
| Mar 2024 | - | $2.38B(-13.9%) | $10.40B(-1.3%) |
| Dec 2023 | $10.54B(-13.1%) | $2.77B(+4.0%) | $10.54B(+4.8%) |
| Sep 2023 | - | $2.66B(+2.5%) | $10.06B(-0.5%) |
| Jun 2023 | - | $2.60B(+2.9%) | $10.11B(-6.6%) |
| Mar 2023 | - | $2.52B(+10.5%) | $10.82B(-10.8%) |
| Dec 2022 | $12.13B(-1.2%) | $2.28B(-16.0%) | $12.13B(-8.0%) |
| Sep 2022 | - | $2.71B(-17.9%) | $13.19B(-5.4%) |
| Jun 2022 | - | $3.31B(-13.7%) | $13.95B(+7.3%) |
| Mar 2022 | - | $3.83B(+14.6%) | $13.00B(+5.8%) |
| Dec 2021 | $12.28B(+38.9%) | $3.34B(-3.8%) | $12.28B(-0.4%) |
| Sep 2021 | - | $3.47B(+47.4%) | $12.33B(+9.9%) |
| Jun 2021 | - | $2.36B(-24.3%) | $11.22B(+8.4%) |
| Mar 2021 | - | $3.11B(-8.2%) | $10.35B(+17.1%) |
| Dec 2020 | $8.84B(+13.9%) | $3.39B(+43.3%) | $8.84B(+16.2%) |
| Sep 2020 | - | $2.37B(+59.3%) | $7.61B(+4.7%) |
| Jun 2020 | - | $1.49B(-7.2%) | $7.27B(-6.9%) |
| Mar 2020 | - | $1.60B(-25.9%) | $7.80B(+0.6%) |
| Dec 2019 | $7.76B(+11.2%) | $2.16B(+6.7%) | $7.76B(+3.5%) |
| Sep 2019 | - | $2.02B(+0.1%) | $7.50B(+4.0%) |
| Jun 2019 | - | $2.02B(+29.9%) | $7.21B(+2.6%) |
| Mar 2019 | - | $1.56B(-17.9%) | $7.02B(+0.7%) |
| Dec 2018 | $6.98B(+13.3%) | $1.90B(+9.3%) | $6.98B(+3.5%) |
| Sep 2018 | - | $1.73B(-5.6%) | $6.74B(+2.0%) |
| Jun 2018 | - | $1.84B(+21.7%) | $6.61B(+11.5%) |
| Mar 2018 | - | $1.51B(-9.2%) | $5.93B(-3.7%) |
| Dec 2017 | $6.16B(+92.6%) | $1.66B(+3.9%) | $6.16B(+5.4%) |
| Sep 2017 | - | $1.60B(+38.3%) | $5.84B(+29.3%) |
| Jun 2017 | - | $1.16B(-33.4%) | $4.52B(-0.2%) |
| Mar 2017 | - | $1.74B(+28.9%) | $4.53B(+41.6%) |
| Dec 2016 | $3.20B(-33.6%) | $1.35B(+384.5%) | $3.20B(+3.6%) |
| Sep 2016 | - | $278.00M(-76.1%) | $3.09B(-21.8%) |
| Jun 2016 | - | $1.17B(+186.2%) | $3.95B(-5.2%) |
| Mar 2016 | - | $407.00M(-67.1%) | $4.16B(-13.6%) |
| Dec 2015 | $4.82B(+14.3%) | $1.24B(+8.7%) | $4.82B(-0.1%) |
| Sep 2015 | - | $1.14B(-17.7%) | $4.82B(+0.7%) |
| Jun 2015 | - | $1.38B(+30.3%) | $4.79B(+6.4%) |
| Mar 2015 | - | $1.06B(-14.6%) | $4.50B(+6.8%) |
| Dec 2014 | $4.22B(+8.0%) | $1.24B(+12.4%) | $4.22B(+4.3%) |
| Sep 2014 | - | $1.10B(+1.0%) | $4.04B(+3.9%) |
| Jun 2014 | - | $1.09B(+41.2%) | $3.89B(+0.4%) |
| Mar 2014 | - | $775.00M(-27.4%) | $3.87B(-5.9%) |
| Dec 2013 | $3.90B(+35.5%) | $1.07B(+11.8%) | $4.11B(+95.5%) |
| Sep 2013 | - | $954.00M(-11.4%) | $2.10B(-8.2%) |
| Jun 2013 | - | $1.08B(+6.0%) | $2.29B(-9.0%) |
| Mar 2013 | - | $1.02B(-207.8%) | $2.52B(-9.8%) |
| Dec 2012 | $2.88B(-37.9%) | -$942.71M(-182.5%) | $2.79B(+19.9%) |
| Sep 2012 | - | $1.14B(-12.4%) | $2.33B(-12.1%) |
| Jun 2012 | - | $1.30B(+1.2%) | $2.65B(-33.2%) |
| Mar 2012 | - | $1.29B(-191.7%) | $3.97B(-14.5%) |
| Dec 2011 | $4.64B(-47.8%) | -$1.41B(-196.0%) | $4.64B(-46.5%) |
| Sep 2011 | - | $1.46B(-44.1%) | $8.67B(-4.7%) |
| Jun 2011 | - | $2.62B(+33.7%) | $9.10B(+2.8%) |
| Mar 2011 | - | $1.96B(-25.4%) | $8.85B(-0.5%) |
| Dec 2010 | $8.89B(-9.3%) | $2.63B(+39.1%) | $8.89B(+1.5%) |
| Sep 2010 | - | $1.89B(-20.2%) | $8.76B(-7.0%) |
| Jun 2010 | - | $2.37B(+18.2%) | $9.41B(+1.4%) |
| Mar 2010 | - | $2.00B(-19.7%) | $9.29B(-5.3%) |
| Dec 2009 | $9.80B(+19.2%) | $2.49B(-2.1%) | $9.80B(-2.6%) |
| Sep 2009 | - | $2.55B(+13.6%) | $10.07B(+6.9%) |
| Jun 2009 | - | $2.24B(-11.1%) | $9.42B(+0.0%) |
| Mar 2009 | - | $2.52B(-8.6%) | $9.41B(+8.9%) |
| Dec 2008 | $8.22B(+27.8%) | $2.76B(+45.6%) | $8.65B(+9.6%) |
| Sep 2008 | - | $1.90B(-15.4%) | $7.89B(+6.3%) |
| Jun 2008 | - | $2.24B(+27.6%) | $7.43B(+9.1%) |
| Mar 2008 | - | $1.76B(-12.3%) | $6.81B(+5.8%) |
| Dec 2007 | $6.43B(+14.6%) | $2.00B(+39.9%) | $6.43B(+9.1%) |
| Sep 2007 | - | $1.43B(-11.8%) | $5.90B(+2.5%) |
| Jun 2007 | - | $1.62B(+17.5%) | $5.75B(+13.5%) |
| Mar 2007 | - | $1.38B(-5.7%) | $5.07B(-0.7%) |
| Dec 2006 | $5.61B(-2.1%) | $1.46B(+14.0%) | $5.10B(-3.3%) |
| Sep 2006 | - | $1.28B(+37.2%) | $5.27B(+1.8%) |
| Jun 2006 | - | $936.39M(-33.8%) | $5.18B(-8.7%) |
| Mar 2006 | - | $1.42B(-13.6%) | $5.67B(-1.1%) |
| Dec 2005 | $5.74B(+5.0%) | $1.64B(+37.6%) | $5.74B(+2.3%) |
| Sep 2005 | - | $1.19B(-16.6%) | $5.61B(-2.6%) |
| Jun 2005 | - | $1.43B(-3.6%) | $5.76B(+2.0%) |
| Mar 2005 | - | $1.48B(-1.9%) | $5.65B(+3.3%) |
| Dec 2004 | $5.47B | $1.51B(+12.4%) | $5.47B(+2.6%) |
| Sep 2004 | - | $1.34B(+2.3%) | $5.32B(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $1.31B(+1.1%) | $5.10B(+18.5%) |
| Mar 2004 | - | $1.30B(-5.0%) | $4.31B(+0.1%) |
| Dec 2003 | $4.20B(-2.4%) | $1.37B(+22.2%) | $4.30B(+19.6%) |
| Sep 2003 | - | $1.12B(+116.2%) | $3.59B(-2.3%) |
| Jun 2003 | - | $518.00M(-59.9%) | $3.68B(-13.0%) |
| Mar 2003 | - | $1.29B(+95.1%) | $4.23B(-1.7%) |
| Dec 2002 | $4.30B(-2.0%) | $662.72M(-45.0%) | $4.30B(-10.7%) |
| Sep 2002 | - | $1.20B(+12.8%) | $4.82B(+3.3%) |
| Jun 2002 | - | $1.07B(-21.9%) | $4.67B(-0.3%) |
| Mar 2002 | - | $1.37B(+16.2%) | $4.68B(+6.5%) |
| Dec 2001 | $4.39B(+3.9%) | $1.18B(+11.8%) | $4.39B(+1.3%) |
| Sep 2001 | - | $1.05B(-2.7%) | $4.34B(+1.8%) |
| Jun 2001 | - | $1.08B(+0.0%) | $4.26B(-0.5%) |
| Mar 2001 | - | $1.08B(-3.6%) | $4.29B(+1.4%) |
| Dec 2000 | $4.23B(+6.3%) | $1.12B(+14.7%) | $4.23B(+2.3%) |
| Sep 2000 | - | $977.61M(-11.5%) | $4.13B(+4.6%) |
| Jun 2000 | - | $1.10B(+7.9%) | $3.95B(+1.7%) |
| Mar 2000 | - | $1.02B(-0.3%) | $3.88B(-2.4%) |
| Dec 1999 | $3.98B(+1.9%) | $1.03B(+29.2%) | $3.98B(+0.0%) |
| Sep 1999 | - | $795.00M(-23.4%) | $3.98B(-2.6%) |
| Jun 1999 | - | $1.04B(-7.1%) | $4.08B(+1.4%) |
| Mar 1999 | - | $1.12B(+8.8%) | $4.03B(+3.2%) |
| Dec 1998 | $3.90B(+9.6%) | $1.03B(+13.9%) | $3.90B(+2.1%) |
| Sep 1998 | - | $901.20M(-8.3%) | $3.82B(+2.2%) |
| Jun 1998 | - | $982.39M(-1.1%) | $3.74B(+2.7%) |
| Mar 1998 | - | $993.40M(+5.0%) | $3.64B(+2.3%) |
| Dec 1997 | $3.56B(+7.9%) | $946.40M(+15.4%) | $3.56B(+1.5%) |
| Sep 1997 | - | $820.10M(-7.3%) | $3.51B(+1.6%) |
| Jun 1997 | - | $884.57M(-3.0%) | $3.45B(+2.3%) |
| Mar 1997 | - | $911.89M(+2.0%) | $3.38B(+2.2%) |
| Dec 1996 | $3.30B(+12.0%) | $893.85M(+17.1%) | $3.30B(+2.2%) |
| Sep 1996 | - | $763.47M(-5.5%) | $3.23B(+2.6%) |
| Jun 1996 | - | $807.60M(-3.7%) | $3.15B(+2.9%) |
| Mar 1996 | - | $838.30M(+1.9%) | $3.06B(+3.8%) |
| Dec 1995 | $2.95B(+11.1%) | $822.79M(+20.6%) | $2.95B(+4.0%) |
| Sep 1995 | - | $682.13M(-5.0%) | $2.84B(+2.4%) |
| Jun 1995 | - | $717.85M(-1.2%) | $2.77B(+1.7%) |
| Mar 1995 | - | $726.56M(+2.5%) | $2.72B(+2.5%) |
| Dec 1994 | $2.65B(+10.2%) | $709.15M(+15.4%) | $2.65B(-0.5%) |
| Sep 1994 | - | $614.63M(-8.5%) | $2.67B(+1.7%) |
| Jun 1994 | - | $671.60M(+1.9%) | $2.62B(+4.8%) |
| Mar 1994 | - | $659.34M(-8.7%) | $2.50B(+3.9%) |
| Dec 1993 | $2.41B(+23.2%) | $721.85M(+26.7%) | $2.41B(+7.0%) |
| Sep 1993 | - | $569.90M(+3.3%) | $2.25B(+0.7%) |
| Jun 1993 | - | $551.50M(-2.4%) | $2.24B(+12.2%) |
| Mar 1993 | - | $564.80M(0.0%) | $1.99B(+2.0%) |
| Dec 1992 | $1.95B(+0.9%) | $564.80M(+1.8%) | $1.95B(+0.6%) |
| Sep 1992 | - | $554.70M(+79.9%) | $1.94B(+5.9%) |
| Jun 1992 | - | $308.30M(-41.4%) | $1.83B(-8.0%) |
| Mar 1992 | - | $526.10M(-4.9%) | $1.99B(+3.0%) |
| Dec 1991 | $1.94B(+9.9%) | $553.30M(+23.8%) | $1.94B(+3.0%) |
| Sep 1991 | - | $446.80M(-4.4%) | $1.88B(+2.1%) |
| Jun 1991 | - | $467.50M(-0.2%) | $1.84B(+1.5%) |
| Mar 1991 | - | $468.40M(-5.7%) | $1.81B(+2.9%) |
| Dec 1990 | $1.76B(+15.3%) | $496.90M(+21.6%) | $1.76B(-222.5%) |
| Sep 1990 | - | $408.80M(-7.1%) | -$1.44B(+168.1%) |
| Jun 1990 | - | $439.90M(+5.6%) | -$536.40M(-256.8%) |
| Mar 1990 | - | $416.50M(-115.4%) | $342.20M(-72.0%) |
| Dec 1989 | $1.53B(+11.3%) | -$2.70B(-306.3%) | $1.22B(-12.5%) |
| Sep 1989 | - | $1.31B(-0.6%) | $1.40B(+7.5%) |
| Jun 1989 | - | $1.32B(+1.8%) | $1.30B(+7.3%) |
| Mar 1989 | - | $1.30B(-151.2%) | $1.21B(+9.7%) |
| Dec 1988 | $1.37B(+9.9%) | -$2.53B(-308.6%) | $1.10B(-25.7%) |
| Sep 1988 | - | $1.21B(-1.4%) | $1.48B(+8.9%) |
| Jun 1988 | - | $1.23B(+3.5%) | $1.36B(+14.3%) |
| Mar 1988 | - | $1.19B(-155.3%) | $1.19B(+18.4%) |
| Dec 1987 | $1.25B(+15.9%) | -$2.15B(-297.0%) | $1.01B(-21.9%) |
| Sep 1987 | - | $1.09B(+2.9%) | $1.29B(+13.2%) |
| Jun 1987 | - | $1.06B(+5.5%) | $1.14B(+11.9%) |
| Mar 1987 | - | $1.00B(-153.8%) | $1.02B(+15.7%) |
| Dec 1986 | $1.08B(+20.7%) | -$1.87B(-298.3%) | $878.60M(-18.3%) |
| Sep 1986 | - | $940.90M(+0.3%) | $1.08B(+12.3%) |
| Jun 1986 | - | $938.00M(+8.4%) | $957.40M(+13.1%) |
| Mar 1986 | - | $865.50M(-151.9%) | $846.40M(+14.8%) |
| Dec 1985 | $892.90M(+10.9%) | -$1.67B(-302.8%) | $737.10M(-11.1%) |
| Sep 1985 | - | $822.70M(-0.5%) | $828.90M(+12.4%) |
| Jun 1985 | - | $827.00M(+9.4%) | $737.40M(+3.6%) |
| Mar 1985 | - | $756.20M(-148.0%) | $711.80M(+5.2%) |
| Dec 1984 | $805.30M | -$1.58B(-315.7%) | $676.70M(-70.0%) |
| Sep 1984 | - | $731.20M(-8.8%) | $2.25B(+48.0%) |
| Jun 1984 | - | $801.40M(+11.1%) | $1.52B(+111.1%) |
| Mar 1984 | - | $721.10M | $721.10M |
FAQ
- What is Abbott Laboratories annual EBITDA?
- What is the all time high annual EBITDA for Abbott Laboratories?
- What is Abbott Laboratories annual EBITDA year-on-year change?
- What is Abbott Laboratories quarterly EBITDA?
- What is the all time high quarterly EBITDA for Abbott Laboratories?
- What is Abbott Laboratories quarterly EBITDA year-on-year change?
- What is Abbott Laboratories TTM EBITDA?
- What is the all time high TTM EBITDA for Abbott Laboratories?
- What is Abbott Laboratories TTM EBITDA year-on-year change?
What is Abbott Laboratories annual EBITDA?
The current annual EBITDA of ABT is $9.11B
What is the all time high annual EBITDA for Abbott Laboratories?
Abbott Laboratories all-time high annual EBITDA is $12.28B
What is Abbott Laboratories annual EBITDA year-on-year change?
Over the past year, ABT annual EBITDA has changed by -$1.44B (-13.64%)
What is Abbott Laboratories quarterly EBITDA?
The current quarterly EBITDA of ABT is $2.54B
What is the all time high quarterly EBITDA for Abbott Laboratories?
Abbott Laboratories all-time high quarterly EBITDA is $3.83B
What is Abbott Laboratories quarterly EBITDA year-on-year change?
Over the past year, ABT quarterly EBITDA has changed by -$227.00M (-8.20%)
What is Abbott Laboratories TTM EBITDA?
The current TTM EBITDA of ABT is $10.36B
What is the all time high TTM EBITDA for Abbott Laboratories?
Abbott Laboratories all-time high TTM EBITDA is $13.95B
What is Abbott Laboratories TTM EBITDA year-on-year change?
Over the past year, ABT TTM EBITDA has changed by -$187.00M (-1.77%)